alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › cholinergic-basal

cholinergic-basal

2 studies tagged cholinergic-basal, dated 2007-12-01 to 2016-07-07. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device 2016-07-07
  2. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease 2007-12-01

Studies

2 studies carry this tag.

Date range

2007 to 2016

Top journals

  • Alzheimer's research & therapy 1
  • Archives of neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's research & therapy 2016-07-07 Biomarkers

    The data derived from this patient cohort demonstrate the safety and tolerability of sustained NGF release by a second-generation NGF-ECB implant to the basal forebrain, with uneventful surgical implant and removal of NGF-ECB implants in a new dosing cohort of four patients with AD.

  2. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Archives of neurology 2007-12-01 Genetics

    Up-regulation of alpha7 nAChRs may signal a compensatory response to maintain basocortical cholinergic activity during AD progression.

All topic tags with their study counts